LeadIQ logo
Learn more at LeadIQ.com

Insights

Phage Therapeutics Market Armata Pharmaceuticals is at the forefront of developing pathogen-specific bacteriophage therapeutics targeting antibiotic-resistant bacterial infections, presenting a key sales opportunity in the phage therapeutics market.

Financial Growth Potential With recent financing of $35M and key investments, Armata Pharmaceuticals exhibits strong financial health, indicating potential for growth and partnership opportunities for sales expansion.

Expansion with Key Personnel The addition of experienced executives like David House as SVP of finance and Deborah L. Birx as CEO signifies a strategic move that can open doors for collaborations, making it a valuable sales proposition for partnerships.

Innovative Science Focus Armata Pharmaceuticals' commitment to rigorous and innovative science in developing bacteriophage therapeutics showcases a unique selling point for engaging potential partners and investors in the biotechnology space.

Market Visibility and Data Publication Recent publications in reputable journals like Communications Biology and positive topline data releases enhance Armata Pharmaceuticals' market visibility, presenting a compelling narrative for sales conversations and business development.

Similar companies to AmpliPhi Biosciences

AmpliPhi Biosciences Tech Stack

AmpliPhi Biosciences uses 8 technology products and services including Matomo, Cloudflare CDN, Twitter Emoji (Twemoji), and more. Explore AmpliPhi Biosciences's tech stack below.

  • Matomo
    Analytics
  • Cloudflare CDN
    Content Delivery Network
  • Twitter Emoji (Twemoji)
    Font Scripts
  • PWA
    Miscellaneous
  • RSS
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Vimeo
    Video Players

Media & News

AmpliPhi Biosciences's Email Address Formats

AmpliPhi Biosciences uses at least 2 format(s):
AmpliPhi Biosciences Email FormatsExamplePercentage
FL@ampliphibio.comJD@ampliphibio.com
44%
FLast@ampliphibio.comJDoe@ampliphibio.com
28%
First.Last@ampliphibio.comJohn.Doe@ampliphibio.com
11%
Last@ampliphibio.comDoe@ampliphibio.com
8%
FirstL@ampliphibio.comJohnD@ampliphibio.com
5%
Last.F@ampliphibio.comDoe.J@ampliphibio.com
4%
FLast@armatapharma.comJDoe@armatapharma.com
96%
LastF@armatapharma.comDoeJ@armatapharma.com
1%
FirstL@armatapharma.comJohnD@armatapharma.com
2%
FMiddleLast@armatapharma.comJMichaelDoe@armatapharma.com
1%

Frequently Asked Questions

Where is AmpliPhi Biosciences's headquarters located?

Minus sign iconPlus sign icon
AmpliPhi Biosciences's main headquarters is located at 4503 Glencoe Ave Marina del Rey, California 90292 US. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is AmpliPhi Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact AmpliPhi Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AmpliPhi Biosciences's stock symbol?

Minus sign iconPlus sign icon
AmpliPhi Biosciences is a publicly traded company; the company's stock symbol is ARMP.

What is AmpliPhi Biosciences's official website and social media links?

Minus sign iconPlus sign icon
AmpliPhi Biosciences's official website is armatapharma.com and has social profiles on LinkedIn.

What is AmpliPhi Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
AmpliPhi Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AmpliPhi Biosciences have currently?

Minus sign iconPlus sign icon
As of January 2021, AmpliPhi Biosciences has approximately 11 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Chief Operating Officer: I. B.Vice President Chemistry Manufacturing And Control: A. G.Executive Assistant To CEO: H. C.. Explore AmpliPhi Biosciences's employee directory with LeadIQ.

What industry does AmpliPhi Biosciences belong to?

Minus sign iconPlus sign icon
AmpliPhi Biosciences operates in the Biotechnology Research industry.

What technology does AmpliPhi Biosciences use?

Minus sign iconPlus sign icon
AmpliPhi Biosciences's tech stack includes MatomoCloudflare CDNTwitter Emoji (Twemoji)PWARSSWP EngineYoast SEOVimeo.

What is AmpliPhi Biosciences's email format?

Minus sign iconPlus sign icon
AmpliPhi Biosciences's email format typically follows the pattern of . Find more AmpliPhi Biosciences email formats with LeadIQ.

How much funding has AmpliPhi Biosciences raised to date?

Minus sign iconPlus sign icon
As of January 2021, AmpliPhi Biosciences has raised $13M in funding. The last funding round occurred on Mar 11, 2015 for $13M.
AmpliPhi Biosciences

AmpliPhi Biosciences

Biotechnology ResearchCalifornia, United States11-50 Employees

Seasoned drug development teams from AmpliPhi Biosciences Corporation and C3J Therapeutics have joined together to form Armata Pharmaceuticals (NYSE American: ARMP) to tackle the global and increasingly serious threat of antimicrobial-resistant bacterial infections. Driven by rigorous and innovative science, Armata is developing high-impact, best-in-class bacteriophage therapeutics with the potential to save millions of lives. Please visit the LinkedIn page at: https://lnkd.in/ga-jvfg and the company website at: www.armatapharma.com

Section iconCompany Overview

Headquarters
4503 Glencoe Ave Marina del Rey, California 90292 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ARMP
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $13M

    AmpliPhi Biosciences has raised a total of $13M of funding over 5 rounds. Their latest funding round was raised on Mar 11, 2015 in the amount of $13M.

Section iconFunding & Financials

  • $13M

    AmpliPhi Biosciences has raised a total of $13M of funding over 5 rounds. Their latest funding round was raised on Mar 11, 2015 in the amount of $13M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.